About Partners Intelligence Log in →
Connecting Israeli Defense Tech to US Needs
Log in

Uvision UAV

Combat-proven loitering munitions delivering precise autonomous strike capability

Israel
51-200

Vitality Radar

80
Current
6M History
Industry
Updated 2 days ago

Pillar Analysis

Presence
Digital footprint, brand visibility, and online reach across channels
76
Business
Revenue signals, funding status, partnerships, and market traction
88
Innovation
R&D activity, patents, product launches, and technology adoption
82
Pulse
Recent momentum — hiring trends, news mentions, and social engagement
70
Capacity
Team strength, leadership depth, and organizational scale
84

Strategic Assessment

Strategic Vector

UVision is positioning itself as a leading global provider of loitering munition systems, leveraging its HERO family to deepen penetration in the U.S. and allied defense markets and expand multi-domain deployment across air, land, and sea.[3][5][7][8]

Efficiency Ratio

The company demonstrates high resource-to-output efficiency, converting a relatively lean headcount and focused infrastructure into major multi-year programs of record and international production footprints.[2][4][7][8]

Evidence Signals

Expansion HIGH Stafford, Virginia, United States

UVision Air Ltd. established UVision USA Corporation in early 2019 as its U.S. production, integration, training, and sustainment center for HERO loitering munitions.

View source
Expansion HIGH Stafford, Virginia, United States

In October 2022, UVision USA opened a 25,000-square-foot production facility at the Quantico Corporate Center in Stafford, Virginia, to increase local HERO systems production and improve responsiveness to U.S. and international customers.

View source
Product Launch HIGH

UVision continues to market and evolve its HERO family of loitering munition systems, including configurations for short-, medium-, and long-range tactical and strategic targets across air, land, and sea domains.

View source
Funding MEDIUM Israel

UVision has raised approximately $17M in funding to date and has reportedly targeted a potential Nasdaq IPO with an aspirational valuation around $3.5B.

View source
Partnership HIGH United States

UVision partnered with U.S.-based Mistral Inc. and in October 2025 won a multi-year, approximately $982M IDIQ contract with the U.S. Army under the LASSO program to procure, field, train, and sustain the HERO-120 loitering munition.

View source
Product Launch HIGH United States

The HERO-120 loitering munition, designed for precision engagement of armored and high-value targets with a 4.5 kg warhead and 40–60 km range, has been adopted by U.S. Special Operations Command in a $73M deal prior to its selection for the U.S. Army LASSO program.

View source
Award HIGH United States

The nearly $1B U.S. Army IDIQ award for the HERO-120 under the LASSO program effectively elevates UVision’s system to a program-of-record status within a major NATO military.

View source
Other HIGH Israel

UVision Air Ltd. is ISO-certified, indicating mature quality management processes for the design and manufacture of its HERO series loitering munition systems.

View source

About
Designs the HERO family of man-in-the-loop loitering munitions with proprietary cruciform aerodynamics, electro-optical guidance, and modular warheads for tactical and strategic precision strikes.
Relevancy
Provides critical precision strike capabilities for military operations with combat-proven loitering munitions across multiple domains. UVision's HERO systems support precision engagement, tactical strikes, and strategic target elimination. Essential for modern military operations, precision warfare, sensor-to-shooter capabilities, and combat effectiveness with proven battlefield deployment and operational validation across multiple conflict zones.
Tags
#loitering-munitions #precision-strike #HERO-systems #combat-proven #multi-domain-weapons #tactical-strikes #strategic-targets #sensor-to-shooter

Suggest an edit

Footer

Connecting Israeli Defense Tech to US Needs

Powered by Meschonomy

Terms Privacy Contact